Nystatin and Pneumonitis aspiration - a phase IV clinical study of FDA data
Summary:
Pneumonitis aspiration is reported as a side effect among people who take Nystatin (nystatin), especially for people who are male, 60+ old, also take Digoxin,.
The phase IV clinical study analyzes which people have Pneumonitis aspiration when taking Nystatin. It is created by eHealthMe based on reports of 33,189 people who have side effects when taking Nystatin from the FDA, and is updated regularly.
What is Nystatin?
Nystatin has active ingredients of nystatin. It is often used in thrush. eHealthMe is studying from 33,567 Nystatin users. Check the latest studies of Nystatin.
What is Pneumonitis aspiration?
Pneumonitis aspiration (acute lung injury after the inhalation of regurgitated gastric contents) is found to be associated with 133 drugs and 13 conditions by eHealthMe. Check the latest studies of Pneumonitis aspiration.
33,189 people reported to have side effects when taking Nystatin.
Among them, 12 people (0.04%) have Pneumonitis aspiration.

Among these 12 people:
What is the gender of people who have Pneumonitis aspiration when taking Nystatin? *
- female: 41.67 %
- male: 58.33 %
What is the age of people who have Pneumonitis aspiration when taking Nystatin? *
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 0.0 %
- 60+: 100 %
What are other drugs people take besides Nystatin? *
- Pepcid: 5 people, 41.67%
- Digoxin: 5 people, 41.67%
- Acetaminophen: 4 people, 33.33%
- Tenormin: 4 people, 33.33%
- Flagyl: 4 people, 33.33%
- Propulsid: 4 people, 33.33%
- M.v.i.: 4 people, 33.33%
- Vancomycin: 4 people, 33.33%
- Albuterol: 4 people, 33.33%
- Bactroban: 3 people, 25.00%
What are other side effects people have besides Pneumonitis aspiration? *
- Hypotension (abnormally low blood pressure): 6 people, 50.00%
- Swallowing Difficulty: 4 people, 33.33%
- Cardiac Arrest: 4 people, 33.33%
- Systemic Sclerosis (Scleroderma) (an autoimmune or connective tissue disease. it is characterized by thickening of the skin): 3 people, 25.00%
- Ventricular Tachycardia (rapid heartbeat that originates in one of the lower chambers (the ventricles) of the heart): 3 people, 25.00%
- Colitis Pseudomembranous (antibiotic-associated diarrhoea): 3 people, 25.00%
- Wound Drainage Increased: 2 people, 16.67%
- Fall: 2 people, 16.67%
- Fainting (loss of consciousness and postural tone): 2 people, 16.67%
- Faecal Incontinence (a lack of control over passing stool): 2 people, 16.67%
* Approximation only. Some reports may have incomplete information.
Do you take Nystatin and have Pneumonitis aspiration?
- Check whether Pneumonitis aspiration is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Nystatin:
- Nystatin (33,567 reports)
Pneumonitis aspiration treatments and more:
- Pneumonitis aspiration (1,163 reports)
How severe was Pneumonitis aspiration and when was it recovered:
Expand to all the drugs that have ingredients of nystatin:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Nystatin:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Pneumonitis aspiration:
- Pneumonitis aspiration (133 drugs)
Browse all the conditions that are associated with Pneumonitis aspiration:
- Pneumonitis aspiration (13 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on nystatin (the active ingredients of Nystatin) and Nystatin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Flexeril cause Pancreatitis? - 2 seconds ago
- Could Pegasys cause Blister? - 3 seconds ago
- Drug interactions of Sulfasalazine and Phenylephrine Hydrochloride - 4 seconds ago
- Could Celebrex cause Loss Of Consciousness? - 14 seconds ago
- Could Vyvanse cause Thyroid Diseases? - 20 seconds ago
- Could Cimzia cause Localised Infection? - 22 seconds ago
- Could Mupirocin cause Injection Site Swelling? - 23 seconds ago
- Could Tagamet cause Sinusitis? - 34 seconds ago
- Could Tagamet cause Sinusitis - Acute? - 34 seconds ago
- Could Flomax cause Dysplasia? - 38 seconds ago